Twist Bioscience Corporation (BIT:1TWST)

Market Cap	1.39B
Revenue (ttm)	308.48M
Net Income (ttm)	-72.54M
Shares Out	n/a
EPS (ttm)	-1.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	131
Average Volume	8
Open	22.97
Previous Close	21.46
Day's Range	22.66 - 22.97
52-Week Range	19.50 - 34.57
Beta	n/a
RSI	45.05
Earnings Date	Nov 17, 2025

About Twist Bioscience

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Employees: 923
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1TWST

Financial Performance

In 2024, Twist Bioscience's revenue was $312.97 million, an increase of 27.69% compared to the previous year's $245.11 million. Losses were -$208.73 million, 2.01% more than in 2023.

Financial numbers in USD